BioLamina

About BioLamina

BioLamina is a Swedish biotechnology company focused on laminin-based cell culture matrices. They provide full-length, human recombinant laminins designed to create biologically relevant, defined niches for 2D and 3D cell culture, with a emphasis on clinical compliance and animal-origin-free formulations. Their products support stem cell maintenance and differentiation, improve reproducibility, and are used across research and potential therapeutic applications, including cell therapy, in vitro tissue models, and regenerative medicine. The company highlights global applications, scalable culture systems, and regulatory-ready materials for research and clinical contexts.